Diabetes wearables-maker Dexcom topped third-quarter earnings forecasts Thursday and reported in-line sales. Dexcom stock was ...

Dexcom topped Wall Street’s expectations for third-quarter earnings, and the company nudged up its guidance for the remainder ...

Medical device company DexCom (NASDAQ:DXCM) reported in Q3 2026, with sales up 11.2% year on year to $1.34 billion. The ...

Updated full-year revenue guidance of $5.20 billion to $5.25 billion passes through Q3 outperformance while factoring in approximately $5 million in incremental foreign exchange headwinds. Management ...

Net Income and Diluted Net Income Per Share: GAAP net income was $275.1 million, or $0.72 per diluted share, for the third ...

Full-year revenue guidance moved from "$5.18 billion to $5.25 billion" in Q2 (Executive VP Sylvain, Q2) to "$5.20 billion to $5.25 billion" in Q3 (Executive VP Sylvain, Q3); Q3 also announced ...

DexCom, Inc. reported revenue of US$1.344 billion for the third quarter ended September 30, 2026, an 11% increase from $1.209 ...

<?xml encoding="utf-8" ?> DexCom DXCM reported third-quarter financial results on Thursday. The transcript from the company’s ...

Dexcom raised full-year revenue guidance again, to $5.20 billion to $5.25 billion, after topping expectations on both lines.

SAN DIEGO (AP) — SAN DIEGO (AP) — DexCom Inc. (DXCM) on Thursday reported third-quarter profit of $275.1 million. The San Diego-based company said it had net income of 72 cents per share. Earnings, ...

Don’t let your Dexcom miss a mile. Three T1D runners share sensor hacks and adhesive tips to keep you race-day ready.

DexCom reported third-quarter 2026 revenue of $1.34 billion, up 11% year-over-year on both a reported and organic basis, powered by a 14% jump in ...